The EGLONYL brand, founded in 1968 (France), from 2757 sister brands and 17478 competing brands. EGLONYL is owned by SANOFI, listed on the stock exchange of Paris The International Securities Identification Number (ISIN) of SANOFI is FR0000120578. EGLONYL belongs to the Drug Manufacturers business sector.